Position in IDYA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,902,252
-$9,262,905 QoQ
Shares Held
1,231,614
-25.6% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 286 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 1%
None 2%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Derivatives in IDYA
reported options exposure · as of Mar 31, 2026CallValue
$2,665,600
CallShares
80,000
PutValue
$5,930,960
PutShares
178,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. IDYA ranks #71 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in IDYA
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,902,252 | 1,231,614 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,665,600 | 80,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $5,930,960 | 178,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $55,165,157 | 1,655,617 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $61,218,836 | 1,770,866 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $33,553,004 | 1,233,113 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,816,426 | 1,228,184 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,369,715 | 816,222 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $45,184,017 | 1,758,133 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $27,535,716 | 869,183 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,760,129 | 676,734 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,381,287 | 418,899 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,897,145 | 278,166 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $11,332,193 | 420,022 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,166,856 | 390,079 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,632,438 | 191,729 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,922,298 | 160,831 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,666,876 | 111,721 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,393,675 | 100,991 | Shares | Defined | 2022-08-18 | |
| 2022-03-31 | $2,148,334 | 191,987 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,470,497 | 104,505 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,424,482 | 55,884 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $786,578 | 37,474 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $808,870 | 34,420 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $411,376 | 29,384 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $129,669 | 10,324 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,248,803 | 158,255 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $108,615 | 26,363 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||